Skip to main content
PLOS One logoLink to PLOS One
. 2026 Mar 2;21(3):e0343502. doi: 10.1371/journal.pone.0343502

Vaping and mental health: A cross-sectional study among university students in Bangladesh

Farah Sabrina 1,2,*, Mohammad Delwer Hossain Hawlader 1,3, Md Nur Alam 1, Md Farhan Ibne Faruq 1, Farah Parisha Bhuiyan 4, Biswajit Banik 5, Muhammad Aziz Rahman 5,6
Editor: Ali Awadallah Saeed7
PMCID: PMC12952649  PMID: 41770786

Abstract

Introduction

Vaping has continued to rise, besides smoking, among youth in Bangladesh in recent years. While there has been evidence of the impact of vaping on physical health, studies focusing on mental health specifically from the South Asian context are almost non-existent. Therefore, this study examines the association between vaping and a spectrum of mental health issues, such as psychological distress, depression, and anxiety, among university students in Bangladesh.

Methods

A cross-sectional study with undergraduate students, aged 18−25 years, from seven universities in Bangladesh, was conducted. Data were collected using a web-based questionnaire. Data on smoking, vaping, and dual use were collected. Psychological distress was measured by using the K10 scale, while the CES-D10 and GAD-7 scales assessed depression and anxiety, respectively. Univariate and multivariate logistic regression analyses determined the relevant associations. Adjusted Odds Ratios (AORs) and 95% Confidence Intervals (CIs) were reported.

Results

Of the 1615 study participants, males and females were distributed equally, and 54% were from two private universities. Findings revealed that one in six (15.4%, n = 248) participants were currently vaping. Exclusive current smokers were 6.2%, exclusive vape users were 6.5%, and dual users were 8.9%. Among vape users, the prevalence of psychological distress (80.5% vs. 76.6%) and depression (63.8% vs. 60.8%) was higher among dual users compared to current vape users; anxiety was similar (56.9% vs. 57.6%) in both groups. After adjusting potential confounders, current vaping was associated with drinking alcohol (AOR 11.43, 95% CI 7.41–17.63) and used of recreational drugs (AOR 4.29, 95% CI 2.36–7.79) However, dual use was associated with higher depression (AOR 1.93; 95% CI 1.04–3.57) and without a preexisting mental health condition was associated with severe anxiety (AOR 2.00, 95% CI 1.25–3.20).

Conclusion

The study underscores a concerning impact on mental health amongst the young group of the population who were vaping, specifically among the dual users. Besides raising awareness, university-based tobacco cessation support and counselling should be considered a student well-being support strategy.

1. Introduction

Vaping has gained remarkable popularity worldwide in recent years, especially among current smokers and young adults [1,2]. The World Health Organization (WHO) reported that the global prevalence of vaping was 1.9% for both sexes, with 2.3% prevalence among males and 1.5% prevalence among females in 2024 [3]. According to the 2018 National Youth Tobacco Survey (NYTS), 3.6 million adolescents in the USA were involved in vaping, with a considerable increase in use recorded between 2017 and 2018. The percentage of adolescents vaping in the USA climbed from 1.5% to 20.8% from 2011 to 2018 [4]. Similar upward trends have been observed in other high-income countries. For instance, in Canada, the proportion of young adults who vaped nearly tripled from 5.7% in 2014 to 15% in 2019 [5]. In Australia, current vaping almost tripled among the population, with a nearly four-fold increase among those aged 18–24 between 2019 (5.3%) and 2022−23 (20.6%) [6]. In Asian contexts, the prevalence of vaping among university students varies considerably, but shows an overall increasing trend, ranging from 4.6% in China [7] to 23% in India [8] and 34.5% in Malaysia [9]. However, research from South Asian settings remains limited, despite the growing popularity of vaping among youth, possibly due to the gradual adoption of Western lifestyle influences [10]. In Bangladesh, the Global Adult Tobacco Survey (GATS) 2017 reported a low vaping prevalence of 0.2% among both males and females [11]. More recent data, however, suggest a sharp rise. A study conducted during the COVID-19 pandemic found a vaping prevalence of 31.3% among young adults [12]. The considerable discrepancy between these findings may reflect differences in target populations, sampling technique, data collection methods, and the evolving social acceptability of vaping rather than an actual epidemic-level surge [12]. Previous studies also indicate that dual use of traditional cigarettes and vaping is common, with many users perceiving vaping as less harmful than smoking [13].

Vaping is increasingly recognized as a public health concern due to its association with multiple adverse health outcomes. It has been linked to nicotine addiction, respiratory damage (including conditions such as “bronchiolitis obliterans” or “popcorn lung”), and cardiovascular risks such as elevated heart rate, hypertension, and atherosclerosis [14]. Moreover, most vapes contain nicotine, which can impair brain development and pose significant health risks to adolescents, young adults, pregnant women, and fetuses [15,16]. Beyond physical harm, emerging evidence suggests that vaping may also affect mental health. Vaping potentially disrupts brain development and fosters unhealthy dependence, especially in adolescents, due to nicotine and other harmful compounds [17]. Vaping can potentially worsen symptoms of stress and anxiety by creating a bidirectional relationship with substance use [18]. In addition, vaping behavior among adolescents and young adults has been associated with an increased risk of substance abuse, such as cannabis, marijuana, or cocaine [14].

A theoretical explanation for the relationship between vaping and mental health can be grounded in biological and psychological mechanisms. Previous molecular-level research showed that nicotine exposure from cigarettes affects neurotransmitter systems such as dopamine and serotonin, which play key roles in mood regulation by deregulating neurotransmitter pathways, causing anxiety and depression [19]. Chronic nicotine use dysregulates these pathways, increasing vulnerability to depression and anxiety. Vaping, containing nicotine, will have a similar mechanism of impact on mental health. Additionally, smoking reduces the activity of the antioxidant enzyme, paraoxonase, which is associated with major depressive disorder due to oxidative stress [20]. Empirical evidence also supports this link; a U.S. CDC study found that 42.1% of students who currently used vape reported moderate-to-severe symptoms of depression and anxiety, compared with 21.0% of students who did not vape (P < .001) [21]. These findings, together with the known neurobiological effects of nicotine, provide a theoretical basis for hypothesizing that vaping may contribute to mental health problems through neurochemical imbalance and oxidative stress pathways [21].

Studies exploring the mental health correlates of vaping remain limited in low and middle-income countries (LMICs). For instance, a recent study in Thailand found that current and dual vape users were more likely to report symptoms of depression and anxiety compared to non-vapers [22]. However, most prior research has focused primarily on the prevalence, motivations for use, and physical health consequences of vaping, with relatively little attention to its mental health implications [8]. To address this gap, the present study aimed to examine the association between vaping and mental health outcomes. Specifically, focusing on psychological distress, anxiety, and depression among undergraduate university students in Bangladesh. This study explored how behavioral factors (vaping), psychological factors (mental health symptoms), and social (youth lifestyle and peer influence) factors interacted within this emerging public health issue.

2. Materials and methods

2.1. Study design and settings

This was a cross-sectional study that continued from 1st February 2024–31st October 2024. It was conducted among undergraduate students from seven universities across Bangladesh. Among the seven universities, two were private, and five were public, and were conveniently selected based on geographic representation and accessibility through the investigators’ collaboration networks. Both private universities and two public universities were located in the capital city of Dhaka, and the other three public universities were selected from the three large metropolitan areas of Chittagong, Sylhet, and Khulna in Bangladesh.

2.2. Study population

Students who were 18–25 years of age, pursuing Bachelor’s degrees in the selected universities, and could respond to an English questionnaire online, were invited to participate in this study.

2.3. Sampling

The sample size was calculated using Open Epi [23]. There was an absence of prior nationally representative data on vaping among university students. A conservative estimate of 30% prevalence of vaping was adopted based on published South Asian studies [8]. Considering that prevalence along with 95% confidence intervals (CIs), and 80% power, the estimated minimum sample size was 323. Convenient sampling was used to recruit the study participants.

2.4. Data collection

After obtaining the ethics approval, an online link to the web-based questionnaire was developed in Google Forms. The survey invitation with the online link and QR code was shared on social media platforms, emails, and text messages with the students in those selected universities. Teachers across different disciplines also circulated the survey link and QR code during the study period. Flyers with survey links and QR codes were also displayed in those universities’ cafeterias, students’ lounges, and libraries. Before accessing the questionnaire, participants were provided with study-related information outlining the purpose, procedures, and confidentiality measures. Only those who voluntarily provided informed consent were able to proceed with the survey. We conducted a pilot study with a small number of university students once the questionnaire was prepared to check the language of the survey. We made necessary modifications in languages before finalising the final version of the questionnaire. The survey was anonymous and self-administered without adding any personal data to minimize response bias. Participants were assured of their confidentiality. The Google Form was configured to allow only one submission per email to avoid double submission. The Google Form required completion of all mandatory fields, and participants could not proceed to the next section without completing each part. Therefore, there were no missing responses, minimizing the possibility of missing data. Before analysis, all responses were screened for completeness and duplicate entries.

2.5. Study tools

A structured survey questionnaire was used. The outcome variable of this study was a spectrum of mental health issues, such as psychological distress, depression, and anxiety, which were assessed using validated and reliable tools. Psychological distress was assessed by the K-10 scale (The Kessler Psychological Distress) [24]. It included ten questions about emotional states, each with a five-level response scale. The K-10 scale had each item graded on a scale of 1(“none of the time”) to 5 (“all of the time”), with scoring from a minimum score of 10 and a maximum score of 50. Higher scores indicated greater distress.

The Center for Epidemiologic Studies Depression Scale–10 (CESD-10) was used to measure depressive symptoms [25,26]. Each item was rated from 0 (“rarely or never”) to 3 (“almost all of the time”), yielding a total score between 0 and 30; higher scores indicated more severe depressive symptoms.

The Generalized Anxiety Disorder Scale (GAD-7) was used to assess anxiety severity [25]. The GAD-7 had seven questions with a 4-point Likert scale. It included seven items rated from 0 (“not at all”) to 3 (“nearly every day”), with total scores ranging from 0 to 21; higher scores indicated greater anxiety severity.

Other variables included in the questionnaire were smoking habits, vaping patterns, the reason for vape use, socio-demographic variables including age, gender, socioeconomic status, living status, student information like university type, academic year, and behavioral issues like drinking alcohol and use of recreational drugs.

2.6. Data analyses

Data were analyzed using STATA (version 17). Descriptive analyses were used to describe the study variables. Categorical variables were expressed as frequencies and percentages. Means and standard deviations were used for continuous variables like age and each scale (K-10, CESD-10, and GAD Scale). To conduct inferential analyses, the scoring of the K-10 tool was grouped into low (score 10–15) and moderate to very high (score 16–50) psychological distress, CESD-10 into no depression (score <10), and depression (score >10), and GAD-7 into minimal to mild anxiety (score 0–9) and moderate to severe anxiety (score 10–21). The association between vaping and all categorical independent variables was examined by using a chi-square test. Fisher’s exact tests were used if a categorical variable had fewer than five observations in a cell. To examine whether the observed associations were independent of underlying psychological vulnerabilities, we conducted a subgroup analysis restricted to students without pre-existing mental health conditions [27]. Bivariate logistic regression was used to identify the association between vaping and mental health outcomes. Then, multivariate logistic regression was used; the model included all independent variables as confounders, which were significant in the chi-square tests at p < 0.20 [28,29]. In the logistic regression analyses, multicollinearity of the independent variables was also verified by looking at the regression coefficients’ standard errors (SEs). The results of bivariate and multivariate logistic regression were presented as odds ratios (ORs) and adjusted odds ratios (AORs), respectively, 95% confidence intervals (CIs) were also reported. All statistics were tested using a two-sided test, and a p-value of <0.05 was considered statistically significant.

2.7. Ethics

Ethical approval was obtained from the Institutional Review Board of North South University in Bangladesh (2020/OR-NSU/IRB/1104). All the data were stored in a password-protected computer of the first author and were only accessible to the research team. All the responses were encrypted during submission and storage. The survey invitation’s plain-language statement mentioned the anonymity of participation. Participation was voluntary, and participants could withdraw at any time during data collection.

3. Results

  • (a)

    Descriptive Results:

A total of 1,615 undergraduate students participated in this study. The characteristics of the study population were detailed in Table 1. Among the study participants, about two-thirds (62.2%) were aged 18–22 years. More than half of the participants (54.0%) were from two private universities. One in nine participants (11.1%) self-reported their mental health status as fair to poor. More than two-thirds of participants (69.2%) experienced moderate to very high levels of psychological distress, more than half (53.0%) exhibited depression, and almost half (49.4%) were dealing with anxiety.

Table 1. Characteristics of the study population.

Characteristics Total, n (%)
Total study participants 1,615
Age
18–22 years 1,004 (62.2)
23–30 years 611 (37.8)
Gender
Male 802 (49.7)
Female 813 (50.3)
University type
Public university 745 (46.1)
Private university 870 (53.9)
Academic year
First to second year 920 (57.0)
Third to final year 695 (43.0)
Socioeconomic status
Low income: (household income BDT 10,000–30,000, equivalent to USD 81.61–244.84 per month) 588 (36.4)
Medium to high-income: Medium (household income BDT 30,001–80,000, equivalent to USD 244.84–652.92), High (household income more than BDT 80,000, equivalent to USD 652.92) 1,027 (63.6)
Marital status
Unmarried 1,506 (93.3)
Married 109 (6.7)
Living status
With family 748 (46.3)
Living alone/ + hostel+ shared flat [not living with family or living independently] 867 (53.7)
Financial contribution to the family
No, I am fully dependent on my family 1,312 (81.2)
Yes, a part of my earnings goes to my family 303 (18.8)
Perception of current social life
Least Satisfied 579 (35.9)
Satisfied 1,036 (64.1)
Comorbidity
No 1,369 (84.8)
Yes 246 (15.2)
Drinking alcohol
No 1,432 (88.7)
Daily 14 (0.9)
Occasionally 169 (10.5)
Use of recreational drugs
No 1,514 (93.7)
Daily 16 (1.0)
Occasionally 85 (5.3)
Diagnosed mental health problem
No 1,435 (88.9)
Yes 180 (11.1)
K-10 scale
Low (score 10–15) 498 (30.8)
Moderate to Very High (score 16–50) 1,117 (69.2)
CESD-10 scale
No Depression (score 0–9) 757 (46.9)
Depression (score 10–30) 858 (53.1)
GAD-7 scale
Minimal to mild anxiety (score 0–9) 817 (50.6)
Moderate to severe anxiety (score 10–21) 798 (49.4)

Table 2 shows, one in six participants (15.3%) reported being current vape users, and (6.2%) were smoking currently. One in eleven (9.0%) were dual-users (used cigarettes and vaping simultaneously). Half of the vape users (50.0%) used them occasionally and had nicotine in the e-juice (58.0%). One-third (37.50%) mentioned curiosity as the primary reason for vaping, and almost a quarter (25.0%) perceived vaping as less addictive than cigarettes.

Table 2. Smoking patterns of the study participants.

Characteristics Total, n (%)
Total Participants 1,615
Smoking Status
Never smoking (cigarettes or vaping) 1,233 (76.4)
Smoking only (Current smokers, never vaped) 100 (6.2)
Current vape users with no prior smoking 22 (1.4)
Current vape users with previous smoking history 82 (5.1)
Dual use (both smoking and vaping) 144 (8.9)
Ex-smokers, never vaped 34 (2.1)
Smoking pattern
No smoking 1,225 (75.8)
Daily smoking 182 (11.3)
Occasional smoking 127 (7.9)
Intention to quit smoking 47 (2.9)
Quit smoking <1year ago 18 (1.1)
Quit smoking >1year ago 16 (0.9)
Vaping
No 1,367 (84.6)
Yes (vaping only + dual use) 248 (15.4)
Reasons for vaping
Curiosity 93 (37.5)
Inspired by friends 65(26.2)
Current trends 46(18.5)
Curiosity/Inspired by friends/ Current trends/Others 44 (17.7)
Types of vaping liquid
With nicotine 144 (58.1)
Without nicotine (only flavors) 85 (34.3)
Without nicotine (no flavors) 19 (7.9)
Nicotine concentration (mg)
Unknown 10 (6.9)
≤6 mg nicotine 35 (24.3)
≤9 mg nicotine 44 (30.5)
≤12 mg nicotine 23 (15.9)
≤16 mg nicotine 32 (22.2)
Perceived that vaping was less addictive than cigarettes
No 213 (13.2)
Yes 402 (24.9)
Don’t know/ Not sure 1,000 (61.9)
Family members have a habit of smoking
No 1,080 (66.8)
Father 379 (23.9)
Mother 1 (0.1)
Sister 152 (9.4)
Brother 3 (0.2)
Perception of effective ways to quit smoking
Counselling 305 (18.9)
Vaping 56 (3.5)
Nicotine replacement drug 29 (1.8)
Nicotine Patch/ Nicotine Lozenge 23 (1.4)
Counselling + Nicotine patch + Traditional medicine 120 (7.4)
Vaping + Nicotine lozenge + Nicotine replacement drug+ Nicotine patch 74 (4.6)
Others 214 (13.3)
Not Sure/ Don’t know 794 (49.2)
Physical effects of using a vape
Dizziness 27 (10.9)
Cough 51 (20.6)
Headache 20 (8.1)
Chest pain/ Shortness of breath 15 (6.1)
Insomnia 14 (5.6)
Decrease Appetite/ Weight loss 49 (19.8)
Cough + Dizziness + Shortness of breath 48 (19.4)
No/ Don’t know 24 (9.7)

Among current vape users, the prevalence of psychological distress (76.6%), depression (60.8%), and anxiety (57.6%) was notably high. Among dual users, psychological distress was 80.5%, depression was 63.8%, and anxiety was 56.9% (Table 3).

Table 3. Prevalence of psychological distress, depression, and anxiety among vape users and dual users.

Current vape users, n (%) Dual users, n (%)
K-10 scale
Low (score 10–15) 58 (23.3) 28(19.4)
Moderate to very high (score 16–50) 190 (76.6) 116 (80.5)
CESD-10 scale
No Depression (score 0–9) 97 (39.1) 52(36.1)
Depression (score 10–30) 151 (60.8) 92 (63.8)
GAD-7 Scale
Minimal to mild anxiety (score 0–9) 105(42.3) 62(43.6)
Moderate to severe anxiety (score 10–21) 143(57.6) 82(56.9)
  • (b)

    Inferential Results:

Associations between current vaping and various socio-demographic factors through multivariate analyses were presented in Table 4. After controlling for all potential confounders(Gender, Academic year, Socioeconomic status, Drinking alcohol, Use of recreational drugs, and Diagnosed mental health problem) it showed that study participants were in the third to final year (AOR 1.66, 95% CI 1.06–2.60), who were from medium to high socioeconomic status (AOR 3.05, 95% CI 1.99–4.70), who used to drink alcohol daily (AOR 11.43, 95% CI 7.41–17.63,), and who used recreational drugs daily (AOR 4.29, 95% CI 2.36–7.79,), who diagnosed mental health problem(OR = 0.33; 95% CI 0.23–0.47; p < 0.001) had higher odds of using vaping.

Table 4. Factors associated with vaping among undergraduate university students in Bangladesh.

Characteristics Current vaping Unadjusted analysis Adjusted analysis*
Yes No
n (%) n (%) p ORs 95% CIs p AORs 95% CIs
Age
18–22 years 111 (11.1) 893 (88.9) <0.001 Ref. 0.606 Ref.
23–30 years 137 (22.4) 474 (77.6) 2.32 1.76 - 3.05 1.12 0.72 - 1.75
Gender
Male 186 (23.2) 616 (76.8) <0.001 Ref. <0.001 Ref.
Female 62 (7.6) 751 (92.4) 0.27 0.20 - 0.37 0.28 0.19 - 0.42
Academic year
First to second year 103 (11.2) 817 (88.8) <0.001 Ref. 0.027 Ref.
Third to final year 145 (20.9) 550 (79.1) 2.09 1.58 - 2.75 1.66 1.06 - 2.60
Socioeconomic status
Low income 46 (7.8) 542 (92.2) <0.001 Ref. <0.001 Ref.
Medium to high-income 202 (19.7) 825 (80.3) 2.88 2.05 - 4.04 3.05 1.99 - 4.70
Marital status
Unmarried 230 (15.3) 1276 (84.7) 0.720 Ref. Not selected in the multivariate model
Married 18 (16.5) 91 (83.5) 1.09 0.64 - 1.85
Living status
With Family 131 (17.5) 617 (82.5) 0.020 Ref. 0.209 Ref.
Living alone+ hostel+ shared flat 117 (13.5) 750 (86.5) 0.73 0.56 - 0.96 0.79 0.55 - 1.13
Financial contribution to the family
No, I am fully dependent on my family 177 (13.5) 1135 (86.5) <0.001 Ref. 0.810 Ref.
Yes, a part of my earnings goes to my family 71 (23.4) 232 (76.6) 1.96 1.44 - 2.67 0.94 0.61 - 1.46
Perception of current social life
Least Satisfied 87 (15.0) 492 (85.0) 0.783 Ref. Not selected in the multivariate model
Satisfied 161 (15.5) 875 (84.5) 1.04 0.78 - 1.38
Comorbidities
No 202 (14.8) 1167 (85.2) 0.115 Ref. Not selected in the multivariate model
Yes 46 (18.7) 200 (81.3) 0.75 0.52 - 1.07
Drinking alcohol
No alcohol 121 (8.4) 1311 (91.6) <0.001 Ref. <0.001 Ref.
Yes (Daily + Occasionally) 127 (69.4) 56 (30.6) 24.57 17.05 −35.41 11.43 7.41 - 17.63
Use of recreational drugs
No 174 (11.5) 1340 (88.5) <0.001 Ref. <0.001 Ref.
Yes (Daily + Occasionally) 74 (73.3) 27 (26.7) 21.10 13.21 −33.70 4.29 2.36 - 7.79
Diagnosed mental health problem
No 191 (13.3) 1244 (86.7) <0.001 Ref. 0.021 Ref.
Yes 57 (31.7) 123 (68.3) 0.33 0.23 - 0.47 0.55 0.33 - 0.91
K-10 scale
Low (score 10–15) 58 (11.6) 440 (88.4) 0.006 Ref. 0.555 Ref.
Moderate to very high (score 16–50) 190 (17.0) 927 (83.0) 1.55 1.13 - 2.13 1.15 0.72 - 1.83
CESD-10 scale
No Depression (score 0–9) 97 (12.8) 660 (87.2) 0.008 Ref. 0.259 Ref.
Depression (score 10–30) 151 (17.6) 707 (82.4) 1.45 1.10 - 1.91 1.26 0.83 - 1.91
GAD-7 Scale
Minimal to mild anxiety (score 0–9) 105 (12.9) 712 (87.1) 0.005 Ref. 0.079 Ref.
Moderate to severe anxiety (score 10–21) 143 (17.9) 655 (82.1) 1.48 1.12 - 1.94 1.46 0.95 - 2.24

** Stepwise multivariate logistic regression analysis was conducted. Variables with p < 0.20 in univariate analysis and those identified as potential confounders (gender, academic year, socioeconomic status, drinking alcohol, recreational drug use, and diagnosed mental health problem) were included in the initial model. Only variables that remained significant at p < 0.05 were presented in the final adjusted model. Adjusted odds ratios (AORs) and 95% confidence intervals (CIs) were shown.

Study participants with moderate to very high levels of psychological distress, depression, and moderate to severe anxiety had higher odds of using vapes in the univariate analyses. Vaping was associated with psychological distress (OR 1.55; 95% CI 1.13–2.13), depression (OR 1.45; 1.10–1.91), and anxiety (OR 1.48;1.12–1.94), although the significance did not remain after adjusting for potential confounders (Table 4).

Table 5 indicates, dual use of vaping and cigarettes was significantly higher among study participants studying at private universities (AOR 2.10, 95% CI 1.19–3.72), being in the third to final year (AOR 2.50, 95% CI 1.30–4.82, P = 0.006), being male (AOR 0.19, 95% CI 0.1–0.33), belonging to medium to high socioeconomic status (AOR 5.54, 95% CI 2.72–11.26), drinking alcohol (AOR 52.97, 95% CI 26.22–107.0), using recreational drugs (AOR 5.74, 95% CI 2.13–15.4), and having depression (AOR 1.93, 95% CI 1.04–3.57). Conversely, those who had been diagnosed with mental health issues (OR 0.27, 95% CI 0.17–0.42) were associated with less likely of dual use.

Table 5. Factors associated with dual use (smoking and vaping) among undergraduate university students in Bangladesh.

Characteristics Dual use (smoking and vaping) Unadjusted analysis Adjusted analysis*
No Yes
n (%) n (%) p ORs 95% CIs p AORs 95% CIs
Age
18–22 years 828 (92.3) 69 (7.7) <0.001 Ref. 0.703 Ref.
23–30 years 405 (84.4) 75 (15.6) 2.22 1.56-3.14 0.88 0.46-1.67
Gender
Male 504 (82.5) 107 (17.5) <0.001 Ref. <0.001 Ref.
Female 729 (95.2) 37 (4.8) 0.23 0.16-0.35 0.19 0.1-0.33
University type
Public university 593 (91.8) 53 (8.2) 0.011 Ref. 0.010 Ref.
Private university 640 (87.6) 91 (12.4) 1.59 1.11-2.27 2.10 1.19-3.72
Academic year
First to second year 760 (92.5) 62 (7.5) <0.001 Ref. 0.006 Ref.
Third to final year 473 (85.2) 82 (14.8) 2.12 1.49-3.01 2.50 1.30 - 4.82
Socioeconomic status
Low income 499 (95.2) 25 (4.8) <0.001 Ref. <0.001 Ref.
Medium to high-income 734 (86.0) 119 (14.0) 3.23 2.07-5.05 5.54 2.72 - 11.26
Marital status
Unmarried 1,151 (89.4) 136 (10.6) 0.615 Ref. Not selected in the multivariate model
Married 82 (91.1) 8 (8.9) 0.82 0.39-1.74
Living status
With Family 557 (88.1) 75 (11.9) 0.116 Ref. Not selected in the multivariate model
Living alone+ hostel+ shared flat 676 (90.7) 69 (9.3) 0.75 0.53-1.07
Financial contribution to the family
No, I am fully dependent on my family. 1,039 (91.6) 95 (8.4) <0.001 Ref. 0.223 Ref.
Yes, a part of my earnings goes to my family. 194 (79.8) 49 (20.2) 2.76 1.89 - 4.02 1.45 0.79 - 2.64
Perception of current social life
Least Satisfied 423 (88.7) 54 (11.3) 0.446 Ref. Not selected in the multivariate model
Satisfied 810 (90.0) 90 (10.0) 0.93 0.78-1.11
Comorbidities
No 1,054 (89.3) 126 (10.7) 0.513 Ref. Not selected in the multivariate model
Yes 179 (90.9) 18 (9.1) 1.18 0.70-1.99
Drinking alcohol
No alcohol 1211 (95.2) 61 (4.8) <0.001 Ref. <0.001 Ref.
Daily alcohol (Occasionally + daily) 22 (21.0) 83 (79.0) 74.89 43.83-128 52.97 26.22–107.0
Use of recreational drugs
No drug 1,222 (92.7) 96 (7.3) <0.001 Ref. <0.001 Ref.
Daily drug (Occasionally + daily) 11 (18.6) 48 (81.4) 55.54 27.93-110.44 5.74 2.13 - 15.48
Diagnosed mental health problem
No 1,136 (91.2) 110 (8.8) <0.001 Ref. 0.024 Ref.
Yes 97 (74.0) 34 (26.0) 0.27 0.17-0.42 0.42 0.20 - 0.89
K-10 scale
Low (score 10–15) 408 (93.6) 28 (6.4) <0.001 Ref. 0.121 Ref.
Moderate to very high (score 16–50) 825 (87.7) 116 (12.3) 2.04 1.33-3.14 1.72 0.86 - 3.41
CESD-10 scale
No depression (score 0–9) 603 (92.1) 52 (7.9) 0.004 Ref. 0.037 Ref.
Depressed (score 10–30) 630 (87.3) 92 (12.7) 1.69 1.18-2.42 1.93 1.04-3.57
GAD-7 scale
Minimal to mild anxiety (score 0–9) 648 (91.3) 62 (8.7) 0.031 Ref. 0.414 Ref.
Moderate to severe anxiety (score 10–21) 585 (87.7) 82 (12.3) 1.46 1.03-2.07 1.29 0.69-2.39

**Stepwise multivariate logistic regression analysis was conducted. Variables with p < 0.20 in univariate analysis and theoretically relevant confounders (gender, university type, academic year, socioeconomic status, alcohol consumption, recreational drug use, diagnosed mental health problem, and CESD-10 scale) were entered into the initial model. Only variables that remained significant at p < 0.05 were presented in the final adjusted model. Adjusted odds ratios (AORs) and 95% confidence intervals (CIs) were shown.

Table 6 shows the factors associated with vaping among the students who did not have pre-existing mental health issues. After adjusting for potential confounders, studying at private universities (AOR 1.53, 95% CI 1.00–2.33), belonging to medium to high socioeconomic status (AOR 3.27, 95% CI 2.01–5.34), drinking alcohol (AOR 11.42, 95% CI 7.10–18.38), using recreational drugs (AOR 5.87, 95% CI 2.81–12.28), and students with moderate to severe anxiety (AOR 2.00, 95% CI 1.25–3.20) were more likely to vape. This subgroup analysis was exploratory and aimed to see if the associations held in students without prior mental health diagnoses; therefore, these findings were interpreted with caution.

Table 6. Factors associated with vaping among undergraduate university students in Bangladesh who did not have pre-existing mental health issues.

Characteristics Use of vaping Unadjusted analysis Adjusted analysis*
No Yes
n (%) n (%) p ORs 95% CIs p AORs 95% CIs
Age
18–22 years 809 (90.1) 89 (9.9) <0.001 Ref. 0.896 Ref.
23–30 years 435 (81.0) 102 (18.9) 2.13 1.56–2.89 1.03 0.63-1.69
Gender
Male 572 (79.2) 150 (20.8) <0.001 Ref. <0.001 Ref.
Female 672 (94.3) 41 (5.8) 0.23 0.16–3.33 0.22 0.14- 0.34
University type
Public university 592 (89.8) 67 (10.2) <0.001 Ref. 0.040 Ref.
Private university 652 (84.0) 124 (15.9) 1.68 1.22-2.30 1.53 1.00-2.33
Academic year
First to second year 743 (90.1) 82 (9.9) <0.001 Ref. 0.181 Ref.
Third to final year 501 (82.1) 109 (17.8) 1.97 1.44-2.68 1.40 0.85–2.29
Socioeconomic status
Low income 491 (93.7) 33 (6.3) <0.001 Ref. <0.001 Ref.
Medium to high-income 753 (82.6) 158 (17.3) 3.12 2.10-4.62 3.27 2.01 −5.34
Marital status
Unmarried 1162 (86.9) 175 (13.1) 0.364 Ref. Not selected in the multivariate model
Married 82 (83.7) 16 (16.3) 1.29 0.74-2.26
Living status
With Family 560 (83.9) 107 (16.0) 0.005 Ref. 0.070 Ref.
Living alone+ Hostel+ shared flat 684 (89.1) 84 (10.9) 0.64 0.47-0.87 0.69 0.46-1.03
Financial contribution to the family
No, I am fully dependent on my family. 1036 (88.1) 140 (11.9) <0.001 Ref. 0.958 Ref.
Yes, a part of my earnings goes to my family. 208 (80.3) 51 (19.7) 1.81 1.27–2.58 1.01 0.62 −1.64
Perception of current social life
Least Satisfied 418 (86.7) 64 (13.3) 0.980 Ref. Not selected in the multivariate model
Satisfied 826 (86.7) 127 (13.3) 1.00 0.72-1.38
Comorbidities
No 1085 (86.9) 163 (13.1) 0.473 Ref. Not selected in the multivariate model
Yes 159 (85.0) 28 (14.9) 1.17 0.75-1.80
Drinking alcohol
No alcohol 1197 (92.3) 100 (7.7) <0.001 Ref. <0.001 Ref.
Daily alcohol (Occasionally + daily) 47 (34.1) 91 (65.9) 23.17 15.42-34.81 11.42 7.10-18.38
Use of recreational drugs
No drug 1227(89.4) 146 (10.6) <0.001 Ref. <0.001 Ref.
Daily drug (Occasionally + daily) 17 (27.4) 45 (72.6) 22.24 12.40-39.88 5.87 2.81 −12.28
K-10 scale
Low (score 10–15) 428 (88.9) 53 (11.0) 0.070 Ref. 0.856 Ref.
Moderate to very high (score 16–50) 816 (85.5) 138 (14.5) 1.36 0.97-1.91 1.04 0.63 −1.72
CESD-10 scale
No depression (score 0–9) 635 (88.2) 85 (11.8) 0.090 Ref. 0.363 Ref.
Depressed (score 10–30) 609 (85.2) 106 (14.8) 1.30 0.95-1.76 1.22 0.79-1.90
GAD-7 scale
Minimal to mild anxiety (score 0–9) 687 (88.9) 85 (11.0) 0.006 Ref. 0.004 Ref.
Moderate to severe anxiety (score 10–21) 557 (84.0) 106 (15.9) 1.53 1.13-2.08 2.00 1.25-3.20

**Stepwise multivariate logistic regression analysis was conducted among participants without pre-existing mental health issues. Variables with p < 0.20 in univariate analysis and known confounders (gender, university type, socioeconomic status, alcohol consumption, recreational drug use, and GAD-7 scale) were included in the model. Variables that remained significant at p < 0.05 were retained in the final model. Adjusted odds ratios (AORs) and 95% confidence intervals (CIs) were shown.

4. Discussion

This cross-sectional study provided an overview of vaping prevalence and the association between vaping and psychological distress, depression, and anxiety among undergraduate students of public and private universities in Bangladesh. Our findings provided critical insights into the various factors associated with that association. We also examined the factors associated with the dual use of vaping and cigarettes. This study was possibly the first study from Bangladesh to examine the association between vaping and mental health status among university students in Bangladesh.

In this study, the prevalence of vaping among undergraduate university students in Bangladesh was 15.4%, with 8.9% of students identified as dual use of vaping and cigarettes. Similarly, in India, 23% of the young population were current vape users [8]. In contrast, these figures were lower than those reported in Malaysia, where 74.9% of students were vapers, and 40.3% were dual users [9]. From 2014 to 2018, the prevalence of current vape users among U.S. adults aged 19–28 rose from 9% to 17% [30]. Another study among university students in the U.S. reported a vaping use rate of 12.8% [31]. Additionally, compared with studies in North America, among students of similar age, 25.2% were daily vape users [32]. In Canada, youth vape users nearly tripled between 2014 and 2019, increasing from 5.7% to 15% [5]. Variations across countries may be explained by differences in regulation, accessibility, affordability, and cultural norms regarding smoking environments [18,33].

In the current study, the main reasons for vaping were curiosity (37.5%), peer pressure (26.2%), and those who had greater concern with social trends (18.5%) were more likely to vape. This finding was consistent with findings from a previous study in Bangladesh [12,13]. In addition, in Malaysia, research showed that, among university students who were exclusive vape users, the main reasons given for vape use were current trend (28.8%), mood disorder (27.8%), and social influence (25.1%) [9]. Disposable vapes gained market share recently due to the affordability and curiosity of users, specifically among young people, high nicotine content, and a variety of flavors, marketing strategies of tobacco companies, and Misconceptions about vaping being a safer alternative to cigarettes also played a role. These findings were interpreted as associations with the motivation of vaping [7,34].

Male students were significantly more likely to vape than female students. A Chinese study showed that males were more likely to vape (6.6% of males and 2.7% of females) [35]. Similarly, A study from Malaysia revealed that 42.3% of vape users were male. In contrast, 3.9% of females used vapes [9]. This gender gap likely reflected sociocultural norms in Asia, within which tobacco use among women was considered socially unacceptable [36].

Furthermore, students from medium to high socioeconomic backgrounds were more likely to have vaped than those from lower-income families. A Malaysian study showed that higher household income was associated with a greater likelihood of vaping among university students. Similarly, people with higher household incomes in China were 1.54 times more likely to have been vape users [9,37]. This might have been linked to greater purchasing power and easier access to vaping products through online platforms and retail outlets among individuals with higher disposable income [33]. Hence, individuals with higher socioeconomic status tended to exhibit a greater likelihood of vaping.

Dual use of cigarettes and vaping was strongly associated with an increased likelihood of experiencing depression, as highlighted by multiple studies conducted in different regions. In this study, multivariate logistic regression revealed that dual users were 1.93 times more likely to be depressed than non-vapers, which might have significant implications for public health. In addition, another study in Thailand also revealed that dual users were 2.30 times more likely to experience moderate to severe depression symptoms compared to non-vape users [22]. Another study in the USA found that both vape and traditional cigarette users were associated with higher depressive symptoms than single-product use, except when disposable vape and cigarettes were both used infrequently [38]. These results suggested that dual use might have reflected greater nicotine exposure, stronger dependence, and existing emotional distress, which might have explained the consistent association with depression observed across different regions.

The possible links between vaping and mental health issues might have been due to the biological effects of nicotine on mood and neurotransmitter systems. Nicotine stimulates the release of dopamine, serotonin, and norepinephrine neurotransmitters that regulate mood, attention, and arousal [22,38]. Young individuals might have been more vulnerable to nicotine’s impact, as exposure during brain development could have increased susceptibility to mood and anxiety problems. Some vapes delivered nicotine more effectively or in higher concentrations, which could have exacerbated these effects. Additionally, the varying chemical composition of e-liquids and additives might have contributed to different mental health outcomes [14]. Repeatedly using a vape to cope with stress or anxiety could have led to an unhealthy dependence on the device, exacerbating existing mental health issues or even contributing to the development of new ones. In turn, vape use could have worsened their mental health [14,15]. These findings warranted strict public health intervention in regulating the use of various chemical compounds in e-cigarettes.

Alcohol and recreational drug use were high among the participants who reported vaping and dual smoking in this study. The odds of drinking alcohol were 11 times higher among non-vapers compared to vapers. In addition, in a large cross-sectional study involving young adults in the USA, one of the reputed universities found a significant link between alcohol use and vaping. They found that Alcohol usage, particularly binge drinking, has the strongest association with vape use. The odds of drinking alcohol were 1.36 times higher for non-vapers [31]. Furthermore, this study found that participants were 4.29 times more likely to use recreational drugs. These findings align with trends observed for other substances, such as alcohol and cannabis, closely mirroring the results of this study [39]. Some other studies in the USA have found that alcohol use, particularly binge drinking, was strongly linked to vape use [40,41]. These findings suggested that vaping might have occurred within a broader spectrum of risk-taking behaviors and substance use patterns among young adults. It was also possible that alcohol and drug use acted as confounding factors in the observed association between vaping and mental health, as both were independently related to psychological distress. Future longitudinal research was warranted to better understand the interrelationship between these behaviors and to clarify causal pathways.

After excluding participants with pre-existing mental health conditions, in the multivariable analysis, students with moderate to severe anxiety were found to be twice as likely to vape compared to those without anxiety symptoms. This suggests that even in the absence of diagnosed mental health disorders, vaping behavior may contribute to anxiety. Similarly, findings from other studies have indicated that individuals with higher odds of anxiety were 2.7 times more likely to engage in vaping [18,22]. People may have used vaping as a coping mechanism to manage stress or regulate emotions, aligning with previous evidence that linked to this study. Causal relationships could not be inferred, and the findings should have been interpreted with caution. Future longitudinal studies were warranted to better understand the temporal and causal pathways between anxiety and vaping behavior.

Despite its strengths in the large sample size of seven universities, this study had several limitations. At first, a convenient sampling was used that did not represent the entire university population in Bangladesh. Secondly, the cross-sectional nature of the study design meant the regression results could only be interpreted as providing insights into associations between vaping and a range of variables; the direction of the relationship between vaping and mental health conditions cannot be established. While psychological distress, depression, and anxiety were analyzed as predictors in this study, it was also possible that vaping behavior might have influenced mental health outcomes. Future longitudinal research will be warranted to clarify these temporal and causal relationships. Thirdly, there was a possibility of reporting bias since no objective measures were used to verify smoking or vaping status. Participants might have underreported their behaviors due to social desirability or stigma associated with vaping and mental health issues, even though the survey was anonymous. There was also a possibility that recall bias might have influenced participants’ ability to accurately report their past behaviors or experiences. Additionally, the use of a convenience sample of university students might have introduced selection bias, limiting the generalizability of the results to the broader young adult population in Bangladesh. Despite those limitations, this was probably the 1st study in Bangladesh where the impact of vaping on mental health status was examined among young people. Future research with a nationally representative sample and a longitudinal study will add further value to inform tobacco control strategies and mental health support for young people in Bangladesh.

5. Conclusion

This study provides new evidence on the association between vaping and mental health status among young undergraduate university students in Bangladesh. The dual use of vaping and cigarettes was more concerning in this study. Factors associated with such associations should be considered for developing smoking cessation interventions as well as mental health support in university settings. In particular, mobile health (mHealth) approaches, such as app-based counselling, text message reminders, and digital behavioral support, could be leveraged to reach students conveniently and confidentially. Additionally, universities could strengthen on-campus counselling programs and peer-support initiatives to address stress, anxiety, and substance use. These results can guide university policies and enhance mental health interventions, fostering support systems such as confidential counselling services for students grappling with recreational drug use and psychological issues.

Supporting information

S1 File. Dataset_Vaping_1615_Sample_.

(XLSX)

pone.0343502.s001.xlsx (461.5KB, xlsx)

Acknowledgments

We also acknowledge the valuable contributions of two student representatives, Bayan Shafique and Tahsin Firdaus for their dedicated support during the data collection process.

Data Availability

All relevant data within the manuscript. Data are available for the corresponding author upon reasonable request.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Lyzwinski LN, Naslund JA, Miller CJ, Eisenberg MJ. Global youth vaping and respiratory health: epidemiology, interventions, and policies. NPJ Prim Care Respir Med. 2022;32(1):14. doi: 10.1038/s41533-022-00277-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Pan L, Morton J, Mbulo L, Dean A, Ahluwalia IB. Electronic cigarette use among adults in 14 countries: A cross-sectional study. EClinicalMedicine. 2022;47:101401. doi: 10.1016/j.eclinm.2022.101401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.World Health Organization. WHO global report on trends in prevalence of tobacco use 2000–2024 and projections 2025–2030. 6th ed. Geneva: World Health Organization; 2025 [Google Scholar]
  • 4.Cullen KA, Ambrose BK, Gentzke AS, Apelberg BJ, Jamal A, King BA. Notes from the Field: Use of Electronic Cigarettes and Any Tobacco Product Among Middle and High School Students - United States, 2011-2018. MMWR Morb Mortal Wkly Rep. 2018;67(45):1276–7. doi: 10.15585/mmwr.mm6745a5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Nguyen HV, Mital S. Effects of e-cigarette use on mental health among youths: quasi-experimental evidence from Canada. Addiction. 2022;117(10):2673–82. doi: 10.1111/add.15943 [DOI] [PubMed] [Google Scholar]
  • 6.Greenhalgh EM, Jenkins S, Scollo MM. 18.9 Influences on the uptake of e-cigarettes. In: Greenhalgh EM, Scollo MM, Winstanley MH, editors. Tobacco in Australia: Facts and issues. Melbourne: Cancer Council Victoria; 2024. [Google Scholar]
  • 7.Wang W, Lu M, Cai Y, Feng N. Awareness and use of e-cigarettes among university students in Shanghai, China. Tob Induc Dis. 2020;18:76. doi: 10.18332/tid/125748 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Pettigrew S, Alvin Santos J, Miller M, Sudhir Raj T, Jun M, Morelli G, et al. E-cigarettes: A continuing public health challenge in India despite comprehensive bans. Prev Med Rep. 2023;31:102108. doi: 10.1016/j.pmedr.2022.102108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Puteh SEW, Manap RA, Hassan TM, Ahmad IS, Idris IB, Sham FM, et al. The use of e-cigarettes among university students in Malaysia. Tob Induc Dis. 2018;16:57. doi: 10.18332/tid/99539 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wipfli H, Bhuiyan MR, Qin X, Gainullina Y, Palaganas E, Jimba M, et al. Tobacco use and E-cigarette regulation: Perspectives of University Students in the Asia-Pacific. Addict Behav. 2020;107:106420. doi: 10.1016/j.addbeh.2020.106420 [DOI] [PubMed] [Google Scholar]
  • 11.Bangladesh Bureau of Statistics and National Tobacco Control Cell. Global Adult Tobacco Survey Bangladesh Report 2017. Available from: https://ntcc.gov.bd/ntcc/uploads/editor/files/GATS%20Report%20Final-2017_20%20MB.PDF [Google Scholar]
  • 12.Hasan MM, Sarker MS, Nazir KH, Rahman MB, Sarker MA, Hosen MI, et al.Electronic cigarettes (vaping) preferences among university students in Bangladesh. Int J Res Appl Sci Eng Technol. 2020;8(IX).doi: 10.22214/ijraset.2020.31357 [DOI] [Google Scholar]
  • 13.Rahman MA, Joseph B, Nimmi N. Electronic Cigarettes or Vaping: Are There Any Differences in the Profiles, Use and Perceptions between a Developed and a Developing Country? Int J Environ Res Public Health. 2022;19(3):1673. doi: 10.3390/ijerph19031673 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Khambayat S, Jaiswal A, Prasad R, Wanjari MB, Sharma R, Yelne S. Vaping Among Adolescents: An Overview of E-Cigarette Use in Middle and High School Students in India. Cureus. 2023;15(5):e38972. doi: 10.7759/cureus.38972 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Tobore TO. On the potential harmful effects of E-Cigarettes (EC) on the developing brain: The relationship between vaping-induced oxidative stress and adolescent/young adults social maladjustment. J Adolesc. 2019;76:202–9. doi: 10.1016/j.adolescence.2019.09.004 [DOI] [PubMed] [Google Scholar]
  • 16.Yoong SL, Hall A, Leonard A, McCrabb S, Wiggers J, Tursan d’Espaignet E, et al. Prevalence of electronic nicotine delivery systems and electronic non-nicotine delivery systems in children and adolescents: a systematic review and meta-analysis. Lancet Public Health. 2021;6(9):e661–73. doi: 10.1016/S2468-2667(21)00106-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Perikleous EP, Steiropoulos P, Paraskakis E, Constantinidis TC, Nena E. E-Cigarette Use Among Adolescents: An Overview of the Literature and Future Perspectives. Front Public Health. 2018;6:86. doi: 10.3389/fpubh.2018.00086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lechner WV, Janssen T, Kahler CW, Audrain-McGovern J, Leventhal AM. Bi-directional associations of electronic and combustible cigarette use onset patterns with depressive symptoms in adolescents. Prev Med. 2017;96:73–8. doi: 10.1016/j.ypmed.2016.12.034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hahad O, Daiber A, Michal M, Kuntic M, Lieb K, Beutel M, et al. Smoking and Neuropsychiatric Disease-Associations and Underlying Mechanisms. Int J Mol Sci. 2021;22(14):7272. doi: 10.3390/ijms22147272 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bortolasci CC, Vargas HO, Souza-Nogueira A, Barbosa DS, Moreira EG, Nunes SOV, et al. Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder. J Affect Disord. 2014;159:23–30. doi: 10.1016/j.jad.2014.02.018 [DOI] [PubMed] [Google Scholar]
  • 21.VanFrank B, Williams TR, Alcantara IC, Hertz M, Al-Shawaf M, Meyers C, et al. E-Cigarette Use and Symptoms of Depression and Anxiety Among US Middle and High School Students. Prev Chronic Dis. 2025;22:E51. doi: 10.5888/pcd22.250186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Phetphum C, Prajongjeep A, Phuengnam K. Relationship between electronic cigarette use, dual smoking habits, and psychological distress among youth in Northern Thailand: A cross-sectional study. Tob Induc Dis. 2024;22:10.18332/tid/186860. doi: 10.18332/tid/186860 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Dean AG, Sullivan KM, Soe MM. Open Epi: Open source epidemiologic statistics for public health. Version 3.01. Available from: https://www.openepi.com
  • 24.Sabrina F, Chowdhury MTH, Nath SK, Imon AA, Quader SMA, Jahan MS, et al. Psychological Distress among Bangladeshi Dental Students during the COVID-19 Pandemic. Int J Environ Res Public Health. 2021;19(1):176. doi: 10.3390/ijerph19010176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Bandiera FC, Loukas A, Wilkinson AV, Perry CL. Associations between tobacco and nicotine product use and depressive symptoms among college students in Texas. Addict Behav. 2016;63:19–22. doi: 10.1016/j.addbeh.2016.06.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10(2):77–84. doi: 10.1016/s0749-3797(18)30622-6 [DOI] [PubMed] [Google Scholar]
  • 27.Taylor E, Brose LS, McNeill A, Brown J, Kock L, Robson D. Associations between smoking and vaping prevalence, product use characteristics, and mental health diagnoses in Great Britain: a population survey. BMC Med. 2023;21(1):211. doi: 10.1186/s12916-023-02890-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Rahman MA, Wilson AM, Sanders R, Castle D, Daws K, Thompson DR, et al. Smoking behavior among patients and staff: a snapshot from a major metropolitan hospital in Melbourne, Australia. Int J Gen Med. 2014;7:79–87. doi: 10.2147/IJGM.S54230 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Rahman MA, Das P, Lam L, Alif SM, Sultana F, Salehin M, et al. Health and wellbeing of staff working at higher education institutions globally during the post-COVID-19 pandemic period: evidence from a cross-sectional study. BMC Public Health. 2024;24(1):1848. doi: 10.1186/s12889-024-19365-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Harlow AF, Han D-H, Eckel SP, McConnell R, Leventhal AM, Barrington-Trimis JL. The interaction of e-cigarette use and mental health symptoms on risk of cigarette smoking initiation among young adults in the United States. Addiction. 2023;118(12):2317–26. doi: 10.1111/add.16319 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Wattick RA, Olfert IM, Olfert MD. Psychosocial Factors Associated with E-Cigarette Use among Young Adults in a 4-Year University in Appalachia. Subst Use Misuse. 2021;56(8):1182–9. doi: 10.1080/10826084.2021.1914102 [DOI] [PubMed] [Google Scholar]
  • 32.US Department of Health and Human Services. Tobacco product use among U.S. middle and high school students - National Youth Tobacco Survey, 2023 (Morbidity and Mortality Weekly Report no 46). Available from: https://www.cdc.gov/mmwr/volumes/72/wr/pdfs/mm7244-H.pdf [DOI] [PMC free article] [PubMed]
  • 33.Baker J, Lenz K, Masood M, Rahman MA, Begg S. Tobacco retailer density and smoking behaviour: how are exposure and outcome measures classified? A systematic review. BMC Public Health. 2023;23(1):2038. doi: 10.1186/s12889-023-16914-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Rahman MA, Hann N, Wilson A, Worrall-Carter L. Electronic cigarettes: patterns of use, health effects, use in smoking cessation and regulatory issues. Tob Induc Dis. 2014;12(1):21. doi: 10.1186/1617-9625-12-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Song H, Yang X, Yang W, Dai Y, Duan K, Jiang X, et al. Cigarettes smoking and e-cigarettes using among university students: a cross-section survey in Guangzhou, China, 2021. BMC Public Health. 2023;23(1):438. doi: 10.1186/s12889-023-15350-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Alahmadi SM, Al-Zalabani AH. Patterns and Factors Associated with E-Cigarette Initiation and Transition Among University Students in Al-Madinah City, Saudi Arabia: A Cross-Sectional Study. Healthcare (Basel). 2025;13(16):1949. doi: 10.3390/healthcare13161949 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Yan D, Lv X, Laestadius L, Wilson FA, Yang M, Martin A, et al. The role of socioeconomic status in the association between advertising exposure and electronic cigarette use among young adults in China: A moderated mediation analys. Tob Induc Dis. 2024;22(February):1–12. doi: 10.18332/tid/183801 [DOI] [Google Scholar]
  • 38.Marsden DG, Loukas A, Chen B, Perry CL, Wilkinson AV. Associations between frequency of cigarette and alternative tobacco product use and depressive symptoms: A longitudinal study of young adults. Addict Behav. 2019;99:106078. doi: 10.1016/j.addbeh.2019.106078 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Omoike OE, Johnson KR. Prevalence of Vaping and Behavioral Associations of Vaping Among a Community of College Students in the United States. J Community Health. 2021;46(1):190–4. doi: 10.1007/s10900-020-00868-y [DOI] [PubMed] [Google Scholar]
  • 40.Frohe T, Leeman RF, Patock-Peckham J, Ecker A, Kraus S, Foster DW. Correlates of cannabis vape-pen use and knowledge among U.S. college students. Addict Behav Rep. 2017;7:32–9. doi: 10.1016/j.abrep.2017.11.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Hefner KR, Sollazzo A, Mullaney S, Coker KL, Sofuoglu M. E-cigarettes, alcohol use, and mental health: Use and perceptions of e-cigarettes among college students, by alcohol use and mental health status. Addict Behav. 2019;91:12–20. doi: 10.1016/j.addbeh.2018.10.040 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Ali Awadallah Saeed

24 Jun 2025

Dear Dr. Sabrina,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 08 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Ali Awadallah Saeed

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

Additional Editor Comments:

Thank you for this important and timely study. I have two points of clarification that I believe would enhance the transparency and rigor of your methodology, before i send the manuscript to reviewers:

University Selection Criteria: Could you please elaborate on the criteria used to select the seven universities across Bangladesh? Specifically, it would be helpful to understand the rationale behind including two private and five public institutions.

Use of Standardized Assessment Tools: Kindly clarify whether permission or ethical approval was obtained for the use of the standardized tools in your study—namely the Kessler Psychological Distress Scale (K-10), the CESD-10, and the GAD-7. Indicating this would strengthen the ethical integrity of the research.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2026 Mar 2;21(3):e0343502. doi: 10.1371/journal.pone.0343502.r002

Author response to Decision Letter 1


6 Jul 2025

PONE-D-25-24214

Vaping and mental health: A cross-sectional study among university students in Bangladesh

PLOS ONE

Dear Dr. Sabrina,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 08 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

• A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

• A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

• An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ali Awadallah Saeed

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response: Thank you for your comments. We addressed this in the revised manuscript. We followed the formatting sample of the author's affiliation and changed it. PLEASE SEE page 1, lines 18 to 19. (Revised Manuscript _20250706_clean file)

2. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

Response: Thank you for your comments. We addressed this in the revised manuscript. All of our ethics statements are only in the METHODS section, PLEASE SEE page 6, lines -173-176. (Revised Manuscript _20250706_clean file)

Additional Editor Comments:

Thank you for this important and timely study. I have two points of clarification that I believe would enhance the transparency and rigor of your methodology, before I send the manuscript to reviewers:

University Selection Criteria: Could you please elaborate on the criteria used to select the seven universities across Bangladesh? Specifically, it would be helpful to understand the rationale behind including two private and five public institutions.

Response: Thank you for your comments. We addressed this in the revised manuscript. we selected these seven universities across Bangladesh. We employed convenience sampling based on the known networks of the investigators to recruit seven universities. PLEASE SEE page no-4, line no-108, 109. (Revised Manuscript _20250706_clean file)

Use of Standardized Assessment Tools: Kindly clarify whether permission or ethical approval was obtained for the use of the standardized tools in your study, namely the Kessler Psychological Distress Scale (K-10), the CESD-10, and the GAD-7. Indicating this would strengthen the ethical integrity of the research.

Response: Thank you for your comments. We addressed this in the revised manuscript. These three scales, namely, the Kessler Psychological Distress Scale (K-10), the Center for Epidemiologic Studies Depression Scale (short form) (CESD-10), and the Generalized Anxiety Disorder scale (GAD-7), are freely available in public domains and do not require any permission for usage for scientific purposes. As such, no additional permission or alike was required for the usage of these scales in this study. Please refer to the following sources for confirmation.

1.https://www.hcp.med.harvard.edu/ncs/k6_scales.php

2.https://eprovide.mapi-trust.org/instruments/center-for-epidemiologic-studies-depression-scale-10

3.https://www.pfizer.com/news/press-release/press-release-detail/pfizer_to_offer_free_public_access_to_mental_health_assessment_tools_to_improve_diagnosis_and_patient_care

Furthermore, we obtained ethics approval from the Institutional Review Board (IRB) of North South University in Bangladesh, with the reference number 2020/OR-NSU/IRB/1104. This approval would have permitted the use of these standardized tools in this study. PLEASE SEE, page no -5,6. line no -148 to 153. (Revised Manuscript _20250706_clean file)

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Response to Reviewers_20250706.docx

pone.0343502.s003.docx (19.2KB, docx)

Decision Letter 1

Ali Awadallah Saeed

29 Sep 2025

Dear Dr. Sabrina,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 13 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Ali Awadallah Saeed

Academic Editor

PLOS ONE

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Partly

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: No

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: No

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: No

Reviewer #2: Yes

**********

Reviewer #1: Comments to the Editor

Dear Editor,

Thanks for the opportunity to review this manuscript. Please find my comments below.

Introduction

The introduction contains several grammatical errors, awkward phrasings, and wordy constructions that make reading difficult. There are issues with sentence structure and clarity in multiple instances.

There is a significant inconsistency in reported vaping prevalence in Bangladesh (from 0.2% to 31.27%) without sufficient explanation of methodological differences between studies. This weakens credibility and may confuse readers.

Several ideas are repeated unnecessarily, such as the harmful effects of nicotine and health risks for pregnant women. These could be condensed to maintain reader engagement and clarity.

The paragraph progression lacks smooth transitions between global trends, regional context, and local findings. The narrative jumps between prevalence, physical effects, and mental health without clear thematic segmentation.

There is no theoretical basis or explanatory model provided to support the hypothesized relationship between vaping and mental health. This weakens the foundation for the research objectives.

While the introduction mentions a lack of studies from developing countries, it does not clearly articulate what specific aspect is missing in current literature or how this study uniquely addresses it.

Some claims, such as describing post-COVID vaping as an “epidemic,” are overstated or emotive without sufficient supporting evidence, affecting the academic tone of the introduction.

The objective of the study is presented at the end but could be more concisely stated and clearly linked to the identified research gap.

Method

Lack of information about how participants were distributed across universities and demographic strata raises concerns about selection bias.

No mention of any blinding, data validation, or procedures to reduce response bias in self-administered surveys.

The assumed 30% vaping prevalence is based on anecdotal evidence, which weakens the scientific rigor of the sample size justification.

Repetition occurs across several parts of the section (e.g., ethical approval mentioned twice, phrasing redundancies in informed consent).

Descriptions of K-10, CESD-10, and GAD-7 are overly long and not consistently formatted.

There's a factual inconsistency in referring to the CESD-10 but citing a source intended for the CESD-20 or CESD-R.

The rationale behind the logistic regression modeling approach and the threshold (p < 0.20) for variable inclusion lacks clarity and justification.

No detail is provided on handling missing data or response validation for online survey submissions.

Ethical approval and consent information are repeated unnecessarily.

Specific details about participant protections (e.g., data encryption or access controls) are not described.

There are formatting inconsistencies.

Results

Several statements repeat information already shown in tables (e.g., prevalence rates of psychological distress, depression, and anxiety among vape and dual users).

Repetition of percentages and exact numbers without analytical interpretation weakens narrative flow.

Terms such as “vaping only-1” and “vaping only-2” are unclear and inconsistently labeled across tables and text.

Typographical issues such as misplaced line breaks and disjointed headings (e.g., Table 2 and vaping descriptions) interrupt readability.

Data analysis leans mostly on descriptive statistics without a clear transition to inferential results.

The rationale for selecting variables into multivariate models is not consistently explained.

Tables show adjusted and unadjusted odds ratios, but variable inclusion criteria in multivariate models are only briefly referenced at the bottom of each table and inconsistently reported.

Some CIs and p-values do not align well with conclusions drawn (e.g., borderline significance interpreted as definitive associations).

There is a lack of clarity on whether mental health outcomes are predictors or outcomes of vaping, especially in subgroup analyses.

The role of diagnosed mental health conditions is inconsistently interpreted—sometimes associated with decreased vaping, other times not explained.

Subgroup analysis for individuals without pre-existing mental health conditions (Table 6) lacks a clear rationale and may inflate Type I error without proper correction or framing.

Transitions between narrative results and table interpretations are abrupt and sometimes fragmented.

Discussion

Key ideas such as the prevalence of vaping in Bangladesh and its rise during COVID-19 are repeated with slight rewording.

The association between vaping and mental health is revisited multiple times across different paragraphs without offering new insights.

Citations are presented back-to-back with little synthesis or interpretation.

External studies are described at length, but their connection to the study’s specific findings is not always clearly established.

Some statements imply causal links (e.g., “compulsion to follow trends” or “mental health could increase vaping”) despite the cross-sectional design.

Phrases like “which is a big public health concern” are emotionally charged and could be more neutrally framed.

Findings from univariate analysis are emphasized even when multivariate analysis showed no significance.

Contradictions occur when interpreting mental health variables as significant in some places but not in others without resolving the inconsistency.

Long paragraphs with multiple ideas (e.g., discussing sex, socioeconomic status, and regional comparisons) affect flow and readability.

Subtopics such as “dual use,” “alcohol and drug use,” and “socioeconomic status” are not clearly delineated.

Terms like “non-users” are inconsistently defined, sometimes meaning non-vapers and other times meaning non-smokers/vapers.

Occasional grammar and syntax issues (e.g., “Contiguity of smoking environments” or “the odds of drinking alcohol were 11 times higher for non-users”).

Explanations for non-significant results in multivariable analyses are brief and speculative.

The role of confounding variables is mentioned but not explored in depth (e.g., impact of alcohol/drug use on mental health and vaping).

Neurobiological explanations for the nicotine-mental health link are mentioned but lack detail or citation depth.

Limitations

Statements like “this warrants strict public health intervention” are not linked to specific policy or intervention models.

Biases like recall bias, selection bias, and the impact of social desirability are acknowledged but not critically examined.

No mention of potential underrepresentation of female users due to cultural factors.

Conclusion

The conclusion largely reiterates prior points without introducing a distinct final perspective.

Recommendations for university mental health policies are broad and not grounded in study findings or feasible actions.

Recommendation

Overall, the study has some merits but is not suitable for publication in its current form. I therefore recommend revision.

Reviewer #2: Dear editor, thank you for the kind invitation to review this paper.

Dear authors thank you for this great work. I ask the authors to address these comments or provide clarifications.

- First, there’s several studies that examine the use of vape and mental health even in developing countries. I advise the authors to focus their aim in literature (novel aspect) on Bangladesh settings, if there’s another novel aspect please correct me and consider it.

- Can you justify the selection of these 7 universities?

- In the study population you mentioned “who could respond to an English questionnaire” can you justify this? How is this not biased to the study population? As I know, the English language is not the official Bangladesh language.

- Can you add more context about the Open Epi and cite it.

- Your sample size was 323 and your final sample was about 1,600 in a data collection period of 10 months. Can you explain this? What was your aim longitudinal study?

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes: Dr Ngozika Esther Ezinne

Reviewer #2: Yes: Dr. Ahmad Mohammad Al Zamel

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2026 Mar 2;21(3):e0343502. doi: 10.1371/journal.pone.0343502.r004

Author response to Decision Letter 2


21 Dec 2025

Reviewer #1: Yes: Dr Ngozika Esther Ezinne

Reviewer #2: Yes: Dr. Ahmad Mohammad Al Zamel

Attachment

Submitted filename: Response to reviewers_comments_20251221_.docx

pone.0343502.s004.docx (71.5KB, docx)

Decision Letter 2

Ali Awadallah Saeed

2 Jan 2026

Dear Dr.  Sabrina,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 16 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Ali Awadallah Saeed

Academic Editor

PLOS One

Journal Requirements:

1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Question to the authors:

The sample-size calculation assumes a 30% prevalence of vaping among university students in Bangladesh, described as anecdotal in the absence of available data. Could you clarify the scientific basis for selecting this value? Please indicate whether it was derived from published studies, pilot data, or a conservative estimation approach, and consider providing an appropriate reference or justification.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Mar 2;21(3):e0343502. doi: 10.1371/journal.pone.0343502.r006

Author response to Decision Letter 3


20 Jan 2026

Response to Editor Comments:

Thank you for the insightful remarks. We appreciate the advice and comments, which undoubtedly improve the quality of our manuscript.

Editor Comment 1

Comment:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Response:

Thank you for your comment. We carefully reviewed all reviewer-recommended references. Relevant and scientifically appropriate publications have been incorporated into the manuscript. References that were not directly aligned with the study objectives or context were not included.

Editor Comment 2

Comment: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response:

We carefully reviewed all the references for completeness, accuracy, compliance with journal guidelines, and retraction status using publisher websites, CrossRef, and PubMed records.

� No retracted articles were identified among the cited references; therefore, no retraction notices were required to be added, and no references were removed for this reason.

� Several technical corrections were made to improve the accuracy and integrity of the reference list, including the removal of duplicate entries. Specifically, References 34, 39, and 41 were identified as duplicates and have therefore been removed from the track-changed version. The references in the Discussion section have been reorganized to maintain correct order and consistency with the updated reference list, both the revised manuscript and the track-changed version.

� There are some corrections of DOIs and formatting errors, which have also been solved. In the track-changed version, in References 2 and 38, their respective DOIs have been formatted. In the clean version and the track changes version, we also addressed it accordingly.

� Harmonization was done between journal titles and citation style to comply with PLOS ONE guidelines.

These changes have been implemented in the revised manuscript and are visible in the tracked-changes file.

Additional Editor Comments

Comment:

The sample-size calculation assumes a 30% prevalence of vaping among university students in Bangladesh, described as anecdotal in the absence of available data. Could you clarify the scientific basis for selecting this value? Please indicate whether it was derived from published studies, pilot data, or a conservative estimation approach, and consider providing an appropriate reference or justification.

Response: Thank you for this important methodological question. We have clarified and strengthened the justification for the assumed 30% prevalence used in the sample size calculation. At the time of study design, no nationally representative data were available on vaping prevalence among Bangladeshi university students. Therefore, we adopted a conservative prevalence estimate informed by published evidence from comparable South Asian populations. We considered regional evidence from South Asia, where vaping prevalence among young adults and university students has been reported to be high. For example, a study from India reported a vaping prevalence of 23% among young people (please see lines 187-188 and page no. 7 on the track changes version). We have now revised the Methods (Section 2.3: Sampling) to explicitly state that “A conservative estimate of 30% prevalence of vaping was adopted based on published South Asian studies [8].” We have cited the relevant literature accordingly. Please see below.

Ref: 8: Pettigrew S, Santos JA, Miller M, Raj TS, Jun M, Morelli G, et al. E-cigarettes: A continuing public health challenge in India despite comprehensive bans. Prev Med Rep. 2023; 31:102108.

doi:10.1016/j.pmedr.2022.102108

Attachment

Submitted filename: Response to Reviewers.docx

pone.0343502.s005.docx (20.5KB, docx)

Decision Letter 3

Ali Awadallah Saeed

8 Feb 2026

Vaping and mental health: A cross-sectional study among university students in Bangladesh

PONE-D-25-24214R3

Dear Dr. Farah Sabrina

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ali Awadallah Saeed

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Ali Awadallah Saeed

PONE-D-25-24214R3

PLOS One

Dear Dr. Sabrina,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ali Awadallah Saeed

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Dataset_Vaping_1615_Sample_.

    (XLSX)

    pone.0343502.s001.xlsx (461.5KB, xlsx)
    Attachment

    Submitted filename: Response to Reviewers_20250706.docx

    pone.0343502.s003.docx (19.2KB, docx)
    Attachment

    Submitted filename: Response to reviewers_comments_20251221_.docx

    pone.0343502.s004.docx (71.5KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0343502.s005.docx (20.5KB, docx)

    Data Availability Statement

    All relevant data within the manuscript. Data are available for the corresponding author upon reasonable request.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES